Neoplasms
Research News and Information

Friday, November 20, 2009

Panton-Valentine leukocidin-positive methicillin-resistant Staphylococcus aureus infections in children with cancer.

13 Dec 2009 BACKGROUND: New strains of methicillin-resistant Staphylococcus aureus (MRSA) which frequently carry the Panton-Valentine leukocidin (PVL) genes have been recognized to cause invasive infections in otherwise healthy children and adults. However, the ... Read more...

Adrenal function testing in pediatric cancer survivors.

13 Dec 2009 BACKGROUND: Central adrenal insufficiency is observed after cranial radiation therapy for cancer. Screening at risk patients is recommended, but the best screening strategy is unknown. METHODS: A retrospective review of pediatric cancer survivors ... Read more...

Vincristine: Can its therapeutic index be enhanced?

13 Dec 2009 Vincristine is one of the most widely used and more effective drugs in paediatric oncology. The dose-limiting toxicity of neuropathy, lack of proven neuroprotective measures and an incomplete understanding of the pharmacokinetics and ... Read more...

Latest indexed articles for 'Neoplasms'

These are the very latest articles for this heading:

• Panton-Valentine leukocidin-positive methicillin-resistant Staphylococcus aureus infections in children with cancer. 13 Dec 2009
• Adrenal function testing in pediatric cancer survivors. 13 Dec 2009
• Vincristine: Can its therapeutic index be enhanced? 13 Dec 2009
• Kinetics of transport and phosphorylation of glucose in cancer cells. 29 Nov 2009
• Model-based projections for deriving up-to-date cancer survival estimates: an international evaluation. 29 Nov 2009
• Serum cholesterol levels in relation to the incidence of cancer: the JPHC study cohorts. 29 Nov 2009
• Factors affecting the delivery of family-centered care in pediatric oncology. 29 Nov 2009
• Health insurance for survivors of childhood cancer: a pre-existing problem. 29 Nov 2009
• Can you cover me now? 29 Nov 2009
• The Canadian Triage Acuity Scale and oncological emergencies in the emergency department: the puzzle pieces may not fit. 29 Nov 2009
• [Montérégie Comprehensive Cancer Care Centre: integrating nurse navigators in Montérégie's oncology teams: one aspect of implementing the Cancer Control Program--Part 1] 29 Nov 2009
• Supporting children of parents who are dying. 29 Nov 2009
• Aging matters in cancer research. 29 Nov 2009
• The shared tumor associated antigen cyclin-A2 is recognized by high-avidity T-cells. 13 Nov 2009
• The Janus-faced role of ezrin in "linking" cells to either normal or metastatic phenotype. 13 Nov 2009
• Absence of IDH2 codon 172 mutation in common human cancers. 13 Nov 2009
• Identification and characterization of binding sites on S100A7, a participant in cancer and inflammation pathways. 8 Nov 2009
• Human papillomavirus vaccine for cancer prevention. 3 Nov 2009
• Inclusion of parents in pediatric subspecialty team rounds: attitudes of the family and medical team. 30 Oct 2009
• Radiotherapy in conjunction with 7-hydroxystaurosporine: a multimodal approach with tumor pO2 as a potential marker of therapeutic response. 30 Oct 2009

See a longer list of these articles.

Technical information about 'Neoplasms'

Definition: New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms.

Descriptor UI: D009369

Alternative terms: Neoplasms; Neoplasm; Tumors; Tumor; Benign Neoplasms; Neoplasms, Benign; Benign Neoplasm; Neoplasm, Benign; Cancer; Cancers;

Related Mesh Headings: Antibodies, Neoplasm; Antigens, Neoplasm; Antineoplastic Agents; Carcinogens; DNA, Neoplasm; Oncogenic Viruses; Precancerous Conditions; RNA, Neoplasm; Pleural Effusion, Malignant; Genes, Tumor Suppressor; Anticarcinogenic Agents;

Allowable Qualifiers: blood; blood supply; cerebrospinal fluid; chemically induced; classification; complications; congenital; diagnosis; diet therapy; drug therapy; economics; embryology; enzymology; ethnology; etiology; genetics; history; immunology; metabolism; microbiology; mortality; nursing; epidemiology; parasitology; pathology; physiopathology; prevention & control; psychology; radiography; radionuclide imaging; radiotherapy; rehabilitation; secretion; surgery; therapy; ultrastructure; urine; veterinary; ultrasonography; chemistry; virology;

Tree Number: C04;

Online Note: pre-explosion = NEOPLASMS (PX)

History Note: /diagnosis was NEOPLASM DIAGNOSIS 1964-65; /etiology was NEOPLASM ETIOLOGY 1964-65; /immunology was NEOPLASM IMMUNOLOGY 1964-65; /radiotherapy was NEOPLASM RADIOTHERAPY 1964-65; /therapy was NEOPLASM THERAPY 1964-65; NEOPLASM STATISTICS was heading 1964-65; CARCINOGENESIS was heading 1977

Technical Notes: avoid: too general; prefer specifics; policy: Manual section 24; /chem ind permitted but consider also CARCINOGENS; /class: consider also NEOPLASM STAGING (see note there) but "grading" = /pathol; /etiol: consider also ONCOGENIC VIRUSES; /vet: Manual 24.6+ or TN 136; TN 135: MeSH terms for neoplasms classed by tissue; /drug ther: consider also ANTINEOPLASTIC AGENTS & its specifics; /genet: consider also GENES, TUMOR SUPPRESSOR /immunol: consider also TUMOR ESCAPE; consider also ANTIGENS, NEOPLASM & ANTIBODIES, NEOPLASM; /microbiol: consider also ONCOGENIC VIRUSES; /nurs = the patient, ONCOLOGIC NURSING = the oncologic specialty; /prev: consider also ANTICARCINOGENIC AGENTS; /radiother = the patient, RADIATION ONCOLOGY = the specialty; consider also BRACHYTHERAPY; /second = NEOPLASM METASTASIS but do not confuse with NEOPLASMS, SECOND PRIMARY; familial: consider also NEOPLASTIC SYNDROMES, HEREDITARY; metastatic cancer of unknown origin: index under NEOPLASM METASTASIS; Tumor Key: TN Suppl